ArticleAnalytical and bioanalytical chemistry2026
Fluorescent and colorimetric dual-readout ratiometric assay for highly selective ascorbic acid detection based on gold(I) triggered in situ reaction.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
A dual-ratiometric assay combining fluorescence and colorimetry is constructed based on a gold(I)-triggered in situ reaction between o-phenylenediamine (OPD) and ascorbic acid (AA). OPD is oxidized by gold(I) to form fluorescent 2,3-diaminophenazine (OPDox), which has an absorption peak centered at 445 nm and a fluorescence emission at 555 nm. When AA is introduced, AA can be oxidized to dehydroascorbic acid (DHAA) by gold(I), inhibiting the production of OPDox. Simultaneously, DHAA reacts with OPD to form a fluorescent quinoxaline derivative (DFQ), which exhibits an absorption peak around 340 nm and a fluorescence emission at 425 nm. Based on this redox-modulated strategy, a highly selective dual-mode sensing assay is established with ratiometric colorimetric (A₃₄₀/A₄₄₅) and ratiometric fluorescence (F₄₂₅/F₅₅₅) signals. This method enables the quantitative analysis of AA, with limits of detection (LOD) of 0.09 μmol/L and 0.04 μmol/L, respectively. Owing to its facile analytical procedure, this assay exhibits many merits including simplicity, excellent selectivity and good biocompatibility, and has been successfully applied to detect AA in human serum samples. Such an approach based on the in situ formation of fluorophores provides a valuable tool for AA detection in clinical diagnosis and drug screening.
Indexed as
Identifiers
42260019What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.